Back

Acute cardiovascular events in type 2 diabetics treated with SGLT2i. Results of a real life registry

13 March 2021 (08:30 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Antidiabetic Pharmacotherapy ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Cristina Goena Vives

Donostia University Hospital, Donostia (Spain)

153 More presentations in this session

Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Portugal
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
Budget impact analysis of antiplatelet therapy with cangrelor in patients with acute coronary artery disease undergoing percutaneous coronary intervention in Belgium
Doctor I. Lizano-Diez (Barcelona, ES)
Abstract
Presentation thumbnail
The clinical significance of blood lactate levels in evaluation of adult patients with Veno-Arterial Extracorporeal Membrane Oxygenation .
Assistant Professor M. Laimoud (Riyadh, SA)
Abstract
Presentation thumbnail
Implantable loop recorder: experience of a center
Doctor C. Marques Pires (Braga, PT)
Abstract
Presentation thumbnail
Bleeding predictors in acute coronary syndrome: does the age or clinical presentation matters?
Doctor C. Marques Pires (Braga, PT)
Abstract

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

ACVC 2021

13 March 2021 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular benefits of SGLT2i in type 2 diabetes without heart failure: a subgroup analysis
30 August 2025
thumbnail
Congress Presentation
Qualifying event proximity, cardiovascular risk, and benefit of empagliflozin in patients with type 2 diabetes and stable atherosclerosis in the EMPA-REG OUTCOME trial
31 August 2019
thumbnail
Congress Presentation
Empagliflozin treatment does not affect the hypertensive response to Ang II administration to rats but decreases oxidative stress in the arterial wall, and endothelial and cardiac dysfunction
1 September 2020
thumbnail
Congress Session
Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources